Introduction to the ACA Panel Discussion

Can the Affordable Care Act survive the new Republican majority in Washington? That depends on whom you ask. In this 12-part HCPLive audio series, three experts debate the merits, flaws, and future of the ACA.

(Click the play button on the audio player above to listen to this segment of the ACA panel discussion)

This HCPLive audio panel discussion features:

  • Joel Zinberg MD, JD, Associate Clinical Professor of Surgery at Mount Sinai Hospital in New York City
  • David Sandman PhD, Senior Vice President of the New York State Health Foundation
  • Patrick Cronin, New Jersey organizing director for “Get Covered America” a nonprofit with a federal contract to help people sign up for coverage
  • Tom Wilson (moderator), a partner at Kaufman Zita Group and former chairman of the NJ Republican State Committee

The panelists look at how well the ACA is working and discuss whether it is politically vulnerable.

Love it or hate it, the Affordable Care Act is now the law of the land. Its supporters and detractors are poles apart.

“We see the ACA as a game-changer,” says Sandman, whose foundation worked to get the New York State health exchange up and running.

But for Zinberg and other detractors, there’s a lot not to like in the ACA. “I’ve been quite critical of the law and various aspects of it,” he says. Conservative groups have vowed to strike down the law.

Cronin, whose non-profit organization officially takes a neutral stance on the merits of the ACA, says, “We want to make the law work.”

Related Videos
Esther Ellen Freeman, MD, PhD: Current Mpox Impact on the Skin
Esther Ellen Freeman, MD, PhD: How COVID-19 Is Affecting Skin Differently in 2023
Megan Noe, MD, MPH: Dermatologists Join the Vaccine Discussion
Berdazimer Gel Provides Complete Molluscum Clearance in 30% of Patients in 12 Weeks
Ester Del Duca, MD: Molecular Phenotype Differences in African Eczema Patients
John Harris, MD, PhD: Advancing Vitiligo Care After Ruxolitinib Cream
Megan Noe, MD, MPH: Navigating Vaccines, COVID-19 Boosters with Dermatology Patients
John Harris, MD, PhD: Year 1 of Ruxolitinib Cream for Vitiligo
Caitlin Treuting: Medical Photography Grows in Pediatric Dermatology
Alberto Pappo, MD: Why Pediatric Melanoma Diagnosis Is In Flux
© 2023 MJH Life Sciences

All rights reserved.